CULTURE CREATED FROM THE STORIES OF SUCCESS
How does Inclusion Win in the Real World?
Creating a more complete team out of the tensions and biases of two interdependent departmental points of view.
This Pharma Research Organization (PRO)* was known for innovative Biomedical Research
But interdisciplinary working cultures had meant that certain perspectives were being underutilised in the developmental processes…
How could an Inclusion Systems approach get everyone working together – towards a better result for the patients and families they wanted to help?
Our process:
Situation:
Communication Problems
Drug discovery and development are core to breakthrough medical treatments. Pre-clinical safety professionals are essential to ensure the safety of every medicine before and after it is administered to patients.
The challenge faced by these professionals was that senior team members, biologists, chemists, and research physicians, often created a relationship with safety team members that would be more appropriate for an outsource provider. The safety team believed their value was being underused in the arrangement.
Inclusion Wins was asked to investigate further.
Problem:
Relationship Framework
Inclusion Wins quickly identified the problem. Existing assumptions within the project teams had led them to draw incomplete conclusions about what the PRO preclinical safety colleagues could provide.
The biases of the PRO project team leaders and the lack of clarity from each safety lead left both missing opportunities, which would help them more effectively reach their individual and collective goals.
Resolution:
Tools for Understanding
During a workshop, the preclinical team learned how to position their outputs around project safety to the project team leaders.
By framing their knowledge within the wider purpose of the project (getting to the most significant result in the most efficient manner) they were able to provide the entire project team with optimal information in the correct context to create a more integrated role throughout many of the PRO discovery programs’ lifecycles.
Conclusion:
Better Results
It could be easy to say that the PRO preclinical team simply felt better about their work; but how did this manifest in a commercial sense?
Fewer bottlenecks were created due to miscommunication at the planning stage, saving valuable time – and by learning more about the drug discovery process (from PRO preclinical safety team members who were troves of experience) and streamlining the teams’ approaches. In short, project teams broadly became more cohesive and created faster, more efficient results.
And that’s before we look at the people-centric (relational) results like job satisfaction, personal satisfaction, trust, and company loyalty…
